A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients.

Gihan Hamdy ElsisiJoão L CarapinhaRania AfifyMohamed Abd ElmotyMohamed Khalaf

Published in: Journal of medical economics (2020)

The results of our BI models suggest that not only does RD treatment have an effect on the budget, but also has major cost savings in other areas which are very important while considering the total costs of MM treatment. This study results provided evidence-based information to the MoH that will help in decision making of whether to implement RD as a treatment intervention or not.

Keyphrases

multiple myeloma
decision making
end stage renal disease
newly diagnosed
chronic kidney disease
low dose
health information
social media
peritoneal dialysis
patient reported outcomes
smoking cessation